Option chain shows key data for Aspira Womens Health's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Aspira Womens Health.

Aspira Womens Health (NASDAQ:AWH) Stock, Option Chain

Aspira Womens Health

Allied World Assurance

Allied World Assurance Company Holdings, AG

NYSE

Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Stock Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

DRCT

DTIL

INCY

INUV

KULR

LGCB

NAOV

OMER

PLAG

POLA

QUBT

REVB

TYRA

USAR

Why Precision BioSciences Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket

Aspira Women&#39;s Health shares are trading higher by 64% during Tuesday&#39;s session. The company secured $1.37 million through a private placement.

Why Aspira Women&#39;s Health (AWH) Stock Is Skyrocketing

Movers_Stocks

ASAN

CRVO

CUTR

FWRG

GMHS

KUKE

LFMD

LZMH

NPWR

SNOA

SPRC

STSS

TNON

TSVT

VYNE

Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Aspira Women's Health Inc. - Common Stock

Aspira Womens Health Inc

ANGO WORLD HOLDINGS INC by ANGO World Holdings, Inc.

Health Care

Press Releases

General

Aspira Women's Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®

Earnings

Aspira Women's Health Reports Selected Third Quarter 2024 Financial Results

Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award

Management

Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

Biotech

Aspira Women's Health Announces the Appointment of Mike Buhle as SVP of Commercial Operations

Aspira Women's Health Announces Appointment of Ellen Beausang to the Board of Directors

Offerings

Aspira Women's Health Submits Request for Withdrawal of Form S-1 Registration Statement

Aspira Women's Health Announces Closing of $1.37 Million Private Placement of Convertible Notes

1606 Corp's (OTC: CBDW) AI to Disrupt $327.6B Gas Station Store & $1.2T Waste Management Industries

Aspira Women's Health Reports Fourth Quarter and Full Year 2024 Financial Results

Comments

Aspira Womens Health

Aspira Womens Health (AWH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga